In the published article, there was an error in the Funding statement.
“This work was funded by the National Research Foundation (NRF) Thuthuka Programme grant 128296 to SM-M. The North-West University, South African Medical Research Council and the University of Zululand is also acknowledged. All the content expressed in this review is the official views of the authors and do not represent that of the North-West University. FM acknowledges funding by the NRF, Thuthuka grant UID 128296 linked to SM-M.”
The correct Funding statement appears below.
“This work was funded by the National Research Foundation (NRF) Thuthuka Programme grant 128296 to SM-M. Funding from North-West University and the University of Zululand is also acknowledged. The work reported herein was made possible through funding by the South African Medical Research Council (SAMRC) through its Division of Research of Capacity Development under the Early Investigators Programme from the South African National Treasury (funding number: HDID8682/MB2022/EIP052). The content hereof is the sole responsibility of the authors and do not necessarily represent the official views of the SAMRC. Also, all the content expressed in this review is the official views of the authors and do not represent that of the North-West University or the University of Zululand. FM acknowledges funding by the NRF, Thuthuka grant UID 128296 linked to SM-M.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
diabetes complications, oxidative stress, inflammation, Moringa (Moringa oleifera), therapeutic targets
Citation
Mthiyane FT, Dludla PV, Ziqubu K, Mthembu SXH, Muvhulawa N, Hlengwa N, Nkambule BB and Mazibuko-Mbeje SE (2023) Corrigendum: A review on the antidiabetic properties of Moringa oleifera extracts: Focusing on oxidative stress and inflammation as main therapeutic targets. Front. Pharmacol. 14:1142410. doi: 10.3389/fphar.2023.1142410
Received
11 January 2023
Accepted
12 January 2023
Published
24 January 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
14 - 2023
Updates
Copyright
© 2023 Mthiyane, Dludla, Ziqubu, Mthembu, Muvhulawa, Hlengwa, Nkambule and Mazibuko-Mbeje.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sithandiwe E. Mazibuko-Mbeje, 36588296@nwu.ac.za
This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.